📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Metacrine

1.1 - Company Overview

Metacrine Logo

Metacrine

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical research and development focused on building an innovative pipeline of best-in-class drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Metacrine

Ilypsa Logo

Ilypsa

HQ: United States Website
  • Description: Provider of renal care pharmaceutical products, discovering, developing, manufacturing, and delivering human therapeutics, including non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. Formerly known as Symyx Therapeutics, Inc., founded in 2002 and based in Santa Clara, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ilypsa company profile →
Verlyx Logo

Verlyx

HQ: Canada Website
  • Description: Provider of liver-targeting therapeutic agents for the treatment of liver diseases, including lead product VLX103, a proprietary form of pentamidine combining hepatoselective and hepatoprotective properties. Privately held pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verlyx company profile →
Crinetics Logo

Crinetics

HQ: United States Website
  • Description: Provider of clinical-stage pharmaceutical research and development focused on therapies for people with rare endocrine diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crinetics company profile →
Madrigal Pharmaceuticals Logo

Madrigal Pharmaceuticals

HQ: United States Website
  • Description: Provider of THR-β-selective agonist therapy for NASH, a once-daily, oral, liver-directed treatment granted accelerated approval by the U.S. FDA. Offers multiple Phase 3 clinical trials in NASH, including in patients with compensated cirrhosis; conducts NASH/MASH R&D focused on the THR-β pathway; and supports educational programs for healthcare professionals on NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Madrigal Pharmaceuticals company profile →
Theratechnologies Logo

Theratechnologies

HQ: Canada Website
  • Description: Provider of biopharmaceutical therapies, including Trogarzo for HIV in individuals with limited treatment options due to resistance, intolerance, or safety considerations; EGRIFTA SV (tesamorelin) to reduce excess abdominal fat in HIV patients with lipodystrophy; and Long Acting Peptides and the SORT1+ oncology platform. Pipeline includes tesamorelin for NASH, F8 bioequivalent formulation, and a multi-dose pen injector in development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theratechnologies company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Metacrine

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Metacrine

2.2 - Growth funds investing in similar companies to Metacrine

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Metacrine

4.2 - Public trading comparable groups for Metacrine

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Metacrine

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Metacrine

What does Metacrine do?

Metacrine is a provider of clinical-stage biopharmaceutical research and development focused on building an innovative pipeline of best-in-class drugs.

Who are Metacrine's competitors?

Metacrine's competitors and similar companies include Ilypsa, Verlyx, Crinetics, Madrigal Pharmaceuticals, and Theratechnologies.

Where is Metacrine headquartered?

Metacrine is headquartered in United States.

How many employees does Metacrine have?

Metacrine has 1,000 employees 🔒.

When was Metacrine founded?

Metacrine was founded in 2010 🔒.

What sector and industry vertical is Metacrine in?

Metacrine is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Metacrine

Who are the top strategic acquirers in Metacrine's sector and industry

Top strategic M&A buyers and acquirers in Metacrine's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Metacrine?

Top strategic M&A buyers groups and sectors for Metacrine include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Metacrine's sector and industry vertical

Which are the top PE firms investing in Metacrine's sector and industry vertical?

Top PE firms investing in Metacrine's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Metacrine's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Metacrine's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Metacrine's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Metacrine include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Metacrine's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Metacrine?

The key public trading comparables and valuation benchmarks for Metacrine include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Metacrine for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Metacrine with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Metacrine's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Metacrine with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Metacrine's' sector and industry vertical?

Access recent funding rounds and capital raises in Metacrine's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Metacrine